Palvella Therapeutics Strengthens Leadership with Appointment of Accomplished Scientist and Biopharmaceutical Executive David W. Osborne, Ph.D. as Chief Innovation Officer

ByQuantisnow·Wall Street's wire, on your screen.

ARQT· Arcutis Biotherapeutics Inc.PVLA· Palvella Therapeutics Inc.

Health Care

Palvella Therapeutics Strengthens Leadership with Appointment of Accomplished Scientist and Biopharmaceutical Executive David W. Osborne, Ph.D. as Chief Innovation Officer | Quantisnow